 LA JOLLA, Calif., Dec. 02, 2020 GLOBE NEWSWIRE -- Artelo Biosciences, Inc. NASDAQ: ARTL , a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced the appointment of drug discovery and development veteran Gregory R. Reyes, M.D., Ph.D. to the Companys Board of Directors, effective November 30, 2020. 